These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7205199)

  • 1. Duchenne muscular dystrophy: systematic neonatal screening and earlier detection of carriers.
    Plauchu H; Dellamonica C; Cotte J; Robert JM
    J Genet Hum; 1980 Dec; 28(4):65-82. PubMed ID: 7205199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic neonatal screening for Duchenne muscular dystrophy].
    Dellamonica C; Robert JM; Cotte J; Plauchu H; Dorche C
    Nouv Presse Med; 1979 Apr; 8(18):1491-3. PubMed ID: 471723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction.
    Greenberg CR; Jacobs HK; Halliday W; Wrogemann K
    Am J Med Genet; 1991 Apr; 39(1):68-75. PubMed ID: 1867267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.
    Hauser E; Toifl K; Mad A; Bittner R
    Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic Duchenne muscular dystrophy in females; genetic counseling of women with pelvifemoral muscular dystrophy.
    Zellweger H; Ionasescu V; Simpson J
    Helv Paediatr Acta; 1980 Sep; 35(4):343-8. PubMed ID: 7451237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systematic neonatal detection of Duchenne's muscular dystrophy. Results after 10 years' of experience in Lyons (France)].
    Plauchu H; Cordier MP; Carrier HN; Dellamonica C; Dorche C; Guibaud P; Lauras B; Cotte J; Robert JM
    J Genet Hum; 1987 Aug; 35(4):217-30. PubMed ID: 3655748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for Duchenne muscular dystrophy.
    Zellweger H; Antonik A
    Pediatrics; 1975 Jan; 55(1):30-4. PubMed ID: 1110862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
    Passos MR; Zatz M
    Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genotypic diagnosis of Duchenne and Becker muscular dystrophies].
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Ann Biol Clin (Paris); 1999; 57(4):417-26. PubMed ID: 10432364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus.
    Drousiotou A; Ioannou P; Georgiou T; Mavrikiou E; Christopoulos G; Kyriakides T; Voyasianos M; Argyriou A; Middleton L
    Genet Test; 1998; 2(1):55-60. PubMed ID: 10464597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relations between delayed diagnosis and forms of onset in Duchenne muscular dystrophy].
    Alvarez Leal M; Morales Aguilera A; Pérez Zuno JA; Segura Romero S; Quiroz Góngora MC; Paredes García A
    Gac Med Mex; 1994; 130(6):459-64. PubMed ID: 7557061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis and modern management of Duchenne muscular dystrophy.
    Miller RG; Hoffman EP
    Neurol Clin; 1994 Nov; 12(4):699-725. PubMed ID: 7845338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of Duchenne muscular dystrophy.
    Maheshwari M; Vijaya R; Kabra M; Arora S; Shastri SS; Deka D; Kriplani A; Menon PS
    Natl Med J India; 2000; 13(3):129-31. PubMed ID: 11558111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rapid screening of the Duchenne muscular dystrophy gene deletion by two multiplex PCR].
    Ma S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):74-8. PubMed ID: 8324844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Newborn screening for Duchenne muscular dystrophy (author's transl)].
    Grimm T
    Monatsschr Kinderheilkd; 1981 Jul; 129(7):414-7. PubMed ID: 6115310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.